Rischin, D., M. R. Migden, A. L. S. Chang, and E. al. “Primary Analysis of Phase 2 Results for Cemiplimab, a Human Monoclonal Anti-PD-1, in Patients With Metastatic Cutaneous Squamous Cell Carcinoma”. SKIN The Journal of Cutaneous Medicine, vol. 2, Dec. 2018, p. S79, doi:10.25251/skin.2.supp.79.